Vaxart Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 6, 2019--Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet…
